Innovation Theater Dinner: Outpatient Realities: Clinical Decision‑Making in a Changing Landscape (non-accredited/non-approved for CECH)
90 min
Wednesday, April 08, 2026
5:45 PM - 7:15 PM
The program will open with brief introductions and a focused overview of today’s outpatient reimbursement environment, covering recent coding updates, documentation expectations, and variability among payers. Dr. Groner and Dr. Davis will then present real-world outpatient cases, explaining their rationale for product selection, strategies for ensuring accurate documentation, and approaches to maintaining clinical focus amid growing administrative pressures.
Jason, serving as a wound care center director, will offer an operational viewpoint, outlining how outpatient programs assess products, support clinicians, and uphold compliance within an evolving regulatory landscape.
The session will conclude by integrating these perspectives, emphasizing how each healthcare professional navigates misinformation, remains grounded in evidence-based practice, and makes confident product decisions as payer policies continue to change.
Objectives:
· Describe the reimbursement landscape in wound care.
· Identify the medical conditions and clinical purposes for which PRP therapy is used.
· Evaluate the benefits and potential therapeutic value of platelet-rich plasma as an adjunct to CAMPs treatments.
· Discuss real world application of CAMPs in the out patient care setting.
Sponsored by Smith+Nephew
Jason, serving as a wound care center director, will offer an operational viewpoint, outlining how outpatient programs assess products, support clinicians, and uphold compliance within an evolving regulatory landscape.
The session will conclude by integrating these perspectives, emphasizing how each healthcare professional navigates misinformation, remains grounded in evidence-based practice, and makes confident product decisions as payer policies continue to change.
Objectives:
· Describe the reimbursement landscape in wound care.
· Identify the medical conditions and clinical purposes for which PRP therapy is used.
· Evaluate the benefits and potential therapeutic value of platelet-rich plasma as an adjunct to CAMPs treatments.
· Discuss real world application of CAMPs in the out patient care setting.
Sponsored by Smith+Nephew
-
Presenter (IT)
-
R. Daniel Davis DPM -
Thomas Groner DPM, CWS -
Jason Demetros MS OTR/L
-
-
Room
- 206